Kaposi sarcoma ( Part 4 ) : Transplant associated kaposi sarcoma : USMLE Step 1
đ đ
đ¨đĨđĨđ¨đ° đ¨đ§ đđ§đŦđđđ đĢđđĻ:- https://www.instagram.com/drgbhanuprakash
đđđŧđļđģ đĸđđŋ đ§đ˛đšđ˛đ´đŋđŽđē đđĩđŽđģđģđ˛đš đđ˛đŋđ˛:- https://t.me/bhanuprakashdr
đđĻđđ¯đđ°đŋđļđ¯đ˛ đ§đŧ đ đ đ đŽđļđšđļđģđ´ đđļđđ:- https://linktr.ee/DrGBhanuprakash
Transplant associated kaposi sarcoma
Occurs months to years after high dose immunosuppressive therapy; 0.2 - 1.0% of kidney transplants
Skin or metastatic lesions present
Skin lesions may regress if immunosuppression is stopped
Usually fatal if spreads to viscera
When KS develops in people whose immune systems have been suppressed after an organ transplant, it is called iatrogenic, or transplant-related KS. Most transplant patients need to take drugs to keep their immune system from rejecting (attacking) the new organ. But by weakening the bodyâs immune system, these drugs increase the chance that someone infected with KSHV (Kaposi sarcoma--associated herpesvirus) will develop KS. Stopping the immune-suppressing drugs or lowering their dose often makes KS lesions go away or get smaller.
#usmlevideos #usmlestep1 #uworld #kaposisarcoma #pathologyvideos #neetpgvideos #mbbs #pathovideos #patholectures #usmlestep1videos #usmlestep1lectures
SORT BY-
āĻļā§āϰā§āώ āĻŽāύā§āϤāĻŦā§āϝ
-
āϏāϰā§āĻŦāĻļā§āώ āĻŽāύā§āϤāĻŦā§āϝ